MedTrace Logo

Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT05509725 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2024-02-20

No results posted yet for this study

Summary

The purpose of the study is to monitor safety and to evaluate the efficacy of a probiotic formulation on abdominal pain, abnormal defecation, comorbid mood disorders (anxiety and depression) as well as general quality of life in adults with IBS-D.

Conditions

  • IBS - Irritable Bowel Syndrome

Interventions

DRUG

Probiotic formulation

Participants will be asked to take 2 doses daily

DRUG

Placebo

Participants will be asked to take 2 doses daily

Sponsors & Collaborators

  • Lallemand Health Solutions

    lead INDUSTRY

Principal Investigators

  • Serhat Bor, Prof. Dr. · Ege University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-11
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05509725 on ClinicalTrials.gov